Capitol Health Limited (AU:CAJ) has released an update.
Integral Diagnostics and Capitol Health have signed a Merger Implementation Deed, set to create a major player in the ANZ diagnostic imaging market with combined revenues of approximately $651 million. Capitol shareholders will receive 0.12849 Integral shares for each Capitol share, resulting in a 63% ownership of the merged entity by Integral shareholders. Anticipated annual pre-tax net cost synergies of at least $10 million are expected, with double-digit earnings per share growth for Integral shareholders in FY25.
For further insights into AU:CAJ stock, check out TipRanks’ Stock Analysis page.
